|
1
|
Siegel R, Desantis C and Jemal A:
Colorectal cancer statistics. CA Cancer J Clin. 64:104–117. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Unal HU, Demiralay E, Tepeoğlu M, Fidan C
and Kilickap S: Lack of relationships between FGF19 staining
pattern, lymph node metastasis and locally invasive characteristics
of the tumor in colorectal cancers. Asian Pac J Cancer Prev.
14:3151–3154. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
de Gramont A: Adjuvant therapy of stage II
and III colon cancer. Semin Oncol. 32(Suppl 8): 11–14. 2005.
View Article : Google Scholar
|
|
4
|
Chen K, Zhang S, Ji Y, et al: Baicalein
inhibits the invasion and metastatic capabilities of hepatocellular
carcinoma cells via down-regulation of the ERK pathway. PLoS One.
8:e729272013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Chaudhary AK, Pandya S, Ghosh K and
Nadkarni A: Matrix metalloproteinase and its drug targets therapy
in solid and hematological malignancies: an overview. Mutat Res.
753:7–23. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Chung TW, Lee YC and Kim CH: Hepatitis B
viral HBx induces matrix metalloproteinase-9 gene expression
through activation of ERK and PI-3K/AKT pathways: involvement of
invasive potential. FASEB J. 18:1123–1125. 2004.PubMed/NCBI
|
|
7
|
Choo EJ, Rhee YH, Jeong SJ, et al:
Anethole exerts antimetatstaic activity via inhibition of matrix
metalloproteinase 2/9 and AKT/mitogen-activated kinase/nuclear
factor kappa B signaling pathways. Biol Pharm Bull. 34:41–46. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Choi YA, Lim HK, Kim JR, et al: Group IB
secretory phospholipase A2 promotes matrix
metalloproteinase-2-mediated cell migration via the
phosphatidylinositol 3-kinase and Akt pathway. J Biol Chem.
279:36579–36585. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kim DH, Hossain MA, Kang YJ, et al:
Baicalein, an active component of Scutellaria baicalensis
Georgi, induces apoptosis in human colon cancer cells and prevents
AOM/DSS-induced colon cancer in mice. Int J Oncol. 43:1652–1658.
2013.PubMed/NCBI
|
|
10
|
Kim SJ, Kim HJ, Kim HR, et al: Antitumor
actions of baicalein and wogonin in HT-29 human colorectal cancer
cells. Mol Med Rep. 6:1443–1449. 2012.PubMed/NCBI
|
|
11
|
Wang L, Ling Y, Chen Y, et al: Flavonoid
baicalein suppresses adhesion, migration and invasion of MDA-MB-231
human breast cancer cells. Cancer Lett. 297:42–48. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yang ZH, Li SN, Liu JX, Guo QX and Sun XW:
MMP-9 polymorphisms are related to serum lipids levels but not
associated with colorectal cancer susceptibility in Chinese
population. Mol Biol Rep. 39:9399–9404. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Chen JS, Wang Q, Fu XH, et al: Involvement
of PI3K/PTEN/AKT/mTOR pathway in invasion and metastasis in
hepatocellular carcinoma: association with MMP-9. Hepatol Res.
39:177–186. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Jung CH, Kim EM, Park JK, et al: Bmal1
suppresses cancer cell invasion by blocking the phosphoinositide
3-kinase-Akt-MMP-2 signaling pathway. Oncol Rep. 29:2109–2113.
2013.PubMed/NCBI
|
|
15
|
Li HL, Zhang S, Wang Y, et al: Baicalein
induces apoptosis via a mitochondrial-dependent caspase activation
pathway in T24 bladder cancer cells. Mol Med Rep. 7:266–270.
2013.PubMed/NCBI
|
|
16
|
Lin YT, Yang JS, Lin HJ, et al: Baicalein
induces apoptosis in SCC-4 human tongue cancer cells via a
Ca2+-dependent mitochondrial pathway. Vivo.
21:1053–1058. 2007.
|
|
17
|
Zhang Z, Lv J, Lei X, et al: Baicalein
reduces the invasion of glioma cells via reducing the activity of
p38 signaling pathway. PLoS One. 9:e903182014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhang Y, Song L, Cai L, Wei R, Hu H and
Jin W: Effects of baicalein on apoptosis, cell cycle arrest,
migration and invasion of osteosarcoma cells. Food Chem Toxicol.
53:325–333. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Waas ET, Hendriks T, Lomme RM and Wobbes
T: Plasma levels of matrix metalloproteinase-2 and tissue inhibitor
of metalloproteinase-1 correlate with disease stage and survival in
colorectal cancer patients. Dis Colon Rectum. 48:700–710. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kim EY, Song HY, Kim JC, et al: Mmp-9
expression after metallic stent placement in patients with
colorectal cancer: association with in-stent restenosis. Radiology.
271:901–908. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Koskensalo S, Hagström J, Linder N, et al:
Lack of MMP-9 expression is a marker for poor prognosis in Dukes' B
colorectal cancer. BMC Clin Pathol. 12:242012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Langers AM, Verspaget HW, Hawinkels LJ, et
al: MMP-2 and MMP-9 in normal mucosa are independently associated
with outcome of colorectal cancer patients. Br J Cancer.
106:1495–1498. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Hsieh CH, Cheng LH, Hsu HH, et al:
Apicidin-resistant HA22T hepatocellular carcinoma cells strongly
activated the Wnt/β-catenin signaling pathway and MMP-2 expression
via the IGF-IR/PI3K/Akt signaling pathway enhancing cell metastatic
effect. Biosci Biotechnol Biochem. 77:2397–2404. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Jin UH, Suh SJ, Chang HW, et al:
Tanshinone IIA from Salvia miltiorrhiza BUNGE inhibits human
aortic smooth muscle cell migration and MMP-9 activity through AKT
signaling pathway. J Cell Biochem. 104:15–26. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Chen JS, Huang XH, Wang Q, et al: Sonic
hedgehog signaling pathway induces cell migration and invasion
through focal adhesion kinase/AKT signaling-mediated activation of
matrix metalloproteinase (MMP)-2 and MMP-9 in liver cancer.
Carcinogenesis. 34:10–19. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhang HB, Lu P, Guo QY, Zhang ZH and Meng
XY: Baicalein induces apoptosis in esophageal squamous cell
carcinoma cells through modulation of the PI3K/Akt pathway. Oncol
Lett. 5:722–728. 2013.PubMed/NCBI
|
